Literature DB >> 20449695

Advancements in the management of urologic chronic pelvic pain: what is new and what do we know?

Justin Parker1, Sorin Buga, Jose E Sarria, Philippe E Spiess.   

Abstract

Prostatitis is one of the most common urologic diagnoses in men of all ages. The etiology of this problem remains poorly understood. No uniform solitary treatment is known for chronic prostatitis. As a result, a multimodal approach is most likely to demonstrate benefit for this disease. Various treatment modalities have included the use of both pharmacologic and nonpharmacologic treatments. In addition, multiple interventional techniques including the injection of botulinum toxin, transurethral needle ablation of the prostate, microwave thermotherapy, neuromodulation, and, most recently, extracorporeal shockwave therapy have been utilized with varying degrees of benefit.

Entities:  

Mesh:

Year:  2010        PMID: 20449695     DOI: 10.1007/s11934-010-0121-9

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  38 in total

Review 1.  Functional somatic syndromes: one or many?

Authors:  S Wessely; C Nimnuan; M Sharpe
Journal:  Lancet       Date:  1999-09-11       Impact factor: 79.321

Review 2.  Heat therapy in the treatment of prostatitis.

Authors:  Scott I Zeitlin
Journal:  Urology       Date:  2002-12       Impact factor: 2.649

3.  Clinical practice. Chronic prostatitis and the chronic pelvic pain syndrome.

Authors:  Anthony J Schaeffer
Journal:  N Engl J Med       Date:  2006-10-19       Impact factor: 91.245

4.  Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial.

Authors:  Jason A Abbott; Sherin K Jarvis; Stephen D Lyons; Angus Thomson; Thierry G Vancaille
Journal:  Obstet Gynecol       Date:  2006-10       Impact factor: 7.661

Review 5.  Using botulinum toxin for pelvic indications in women.

Authors:  Archana Rao; Jason Abbott
Journal:  Aust N Z J Obstet Gynaecol       Date:  2009-08       Impact factor: 2.100

6.  Citalopram in the treatment of women with chronic pelvic pain: an open-label trial.

Authors:  Candace S Brown; Andrea S Franks; Jim Wan; Frank W Ling
Journal:  J Reprod Med       Date:  2008-03       Impact factor: 0.142

7.  Treatment for chronic prostatitis/chronic pelvic pain syndrome: levofloxacin, doxazosin and their combination.

Authors:  Chang Wook Jeong; Dae Jung Lim; Hwancheol Son; Sang Eun Lee; Hyeon Jeong
Journal:  Urol Int       Date:  2008-03-19       Impact factor: 2.089

8.  Therapeutic effect of transurethral needle ablation in non-bacterial prostatitis: chronic pelvic pain syndrome type IIIa.

Authors:  Po Hui Chiang; Chin Pei Chiang
Journal:  Int J Urol       Date:  2004-02       Impact factor: 3.369

9.  A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study.

Authors:  Florian M E Wagenlehner; Henning Schneider; Martin Ludwig; Jörg Schnitker; Elmar Brähler; Wolfgang Weidner
Journal:  Eur Urol       Date:  2009-06-03       Impact factor: 20.096

10.  Transurethral microwave thermotherapy for nonbacterial prostatitis: a randomized double-blind sham controlled study using new prostatitis specific assessment questionnaires.

Authors:  J C Nickel; R Sorensen
Journal:  J Urol       Date:  1996-06       Impact factor: 7.450

View more
  4 in total

Review 1.  Surgical therapy of prostatitis: a systematic review.

Authors:  Dominik S Schoeb; Daniel Schlager; Martin Boeker; Ulrich Wetterauer; Martin Schoenthaler; Thomas R W Herrmann; Arkadiusz Miernik
Journal:  World J Urol       Date:  2017-06-13       Impact factor: 4.226

2.  Low Energy Shock Wave Therapy Inhibits Inflammatory Molecules and Suppresses Prostatic Pain and Hypersensitivity in a Capsaicin Induced Prostatitis Model in Rats.

Authors:  Hung-Jen Wang; Pradeep Tyagi; Yu-Ming Chen; Michael B Chancellor; Yao-Chi Chuang
Journal:  Int J Mol Sci       Date:  2019-09-26       Impact factor: 5.923

3.  Intraprostatic injection of botulinum toxin-A in patients with refractory chronic pelvic pain syndrome: The transurethral vs. transrectal approach.

Authors:  Mohamed A El-Enen; Mohamed Abou-Farha; Ahmed El-Abd; Hassan El-Tatawy; Ahmed Tawfik; Shawky El-Abd; Mohamed Rashed; Mahmoud El-Sharaby
Journal:  Arab J Urol       Date:  2015-02-09

Review 4.  Male chronic pelvic pain: An update.

Authors:  Christopher P Smith
Journal:  Indian J Urol       Date:  2016 Jan-Mar
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.